Gillespie, Nathan A.
Su, Mei-Hsin
Lannoy, Séverine
Stephenson, Mallory
RenterÃa, Miguel E.
Ceja, Zuriel
Hickie, Ian B.
Martin, Nicholas G.
Edwards, Alexis C.
Funding for this research was provided by:
United States National Institute on Drug Abuse (R00DA023549)
United States National Institute of Mental Health (K99AA030611)
United States National Institute of Mental Health (R01MH129356)
United States National Institute of Mental Health (R01MH129356)
United States National Institute of Mental Health (R01MH129356)
United States National Institute of Mental Health (R01MH129356)
United States National Institute of Mental Health (R01MH129356)
United States National Institute of Mental Health (R01MH129356)
Rebecca L Cooper Medical Research Foundation through an Al & Val Rosenstrauss Fellowship (F20231230)
Rebecca L Cooper Medical Research Foundation through an Al & Val Rosenstrauss Fellowship (F20231230)
Beyond Blue
Australian National Health and Medical Research Council Australia Fellowship (464914)
Australian National Health and Medical Research Council Australia Fellowship (464914)
Australian National Health and Medical Research Council (901061, 950998, 241944)
Australian National Health and Medical Research Council (901061, 950998, 241944)
Queensland Cancer Fund, Australian Research Council (A79600334, A79801419, A79906588, DP0212016)
Queensland Cancer Fund, Australian Research Council (A79600334, A79801419, A79906588, DP0212016)
Human Frontiers Science Program (RG0154/1998-B)
Human Frontiers Science Program (RG0154/1998-B)
Article History
Received: 20 December 2024
Accepted: 3 September 2025
First Online: 24 September 2025
Declarations
:
: The authors declare no competing interests.